The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Navigating chemical space for biology and medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Self-citationLipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Self-citationMolecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Self-citationThe growing impact of click chemistry on drug discovery
Kolb, H. C., & Sharpless, K. B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02933-7 · Cited by 3,716
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Self-citationEncyclopedia of Computational Chemistry
(1998) · Wiley eBooks · doi:10.1002/0470845015 · Cited by 2,742
Encyclopedia of Computational Chemistry
Horn, A., & Lanig, H. (1999) · Journal of Molecular Modeling · doi:10.1007/s0089490050141 · Cited by 2,511
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“Examples of such proteins are the many proteins that participate in protein–protein interactions in biological signalling cascade”
Simple Selection Criteria for Drug-like Chemical Matter
Muegge, I., Heald, S. L., & Brittelli, D. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015507e · Cited by 1,315
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Rees, D. C., Congreve, Murray, C. W., & Carr, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 798
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
Functional group contributions to drug-receptor interactions
Andrews, P. R., Craik, D. J., & Martin, J. L. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a021 · Cited by 535
High-throughput crystallography for lead discovery in drug design
Blundell, T. L., Jhoti, H., & Abell, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd706 · Cited by 530
Methods and Principles in Medicinal Chemistry
(2008) · Methods and principles in medicinal chemistry · doi:10.1002/series6138 · Cited by 514
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives
Bunin, B. A., & Ellman, J. A. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00053a067 · Cited by 443
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Selection criteria for drug‐like compounds
Muegge, I. (2003) · Medicinal Research Reviews · doi:10.1002/med.10041 · Cited by 412
Chemical genetics resulting from a passion for synthetic organic chemistry
Schreiber, S. L. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00126-6 · Cited by 410
Biochemical mechanisms of drug action: what does it take for success?
Swinney, D. C. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1500 · Cited by 394
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Tethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385
Nonleadlikeness and leadlikeness in biochemical screening
Rishton, G. M. (2003) · Drug Discovery Today · doi:10.1016/s1359644602025722 · Cited by 381
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Chemography: The Art of Navigating in Chemical Space
Oprea, T. I., & Gottfries, J. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc0000388 · Cited by 353
Reactive compounds and in vitro false positives in HTS
Rishton, G. M. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01083-0 · Cited by 351
NIH Molecular Libraries Initiative
Austin, C. P., Brady, L. S., Insel, T. R., & Collins, F. S. (2004) · Science · doi:10.1126/science.1105511 · Cited by 348
Discovering novel ligands for macromolecules using X-ray crystallographic screening
Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322
Recognizing molecules with drug-like properties
Walters, W. P., Murcko, A. A., & Murcko, M. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80058-1 · Cited by 266
Comprehensive Survey of Combinatorial Library Synthesis: 2000
Dolle, R. E. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc010049g · Cited by 256
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Horrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
Kinase Inhibitors: Not Just for Kinases Anymore
McGovern, S. L., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020427b · Cited by 230
Selective Optimization of Side Activities: Another Way for Drug Discovery
Wermuth, C. G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030480f · Cited by 201
Predicting ADME properties and side effects: the BioPrint approach.
Krejsa, C. M., Horvath, D., Rogalski, S. L., Penzotti, J. E., Mao, B., Barbosa, F., & Migeon, J. (2003) · PubMed · Cited by 176
Allosteric Inhibition Through Core Disruption
Horn, J. R., & Shoichet, B. K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.068 · Cited by 150
Drug prototypes and their exploitation
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)84366-8 · Cited by 147
SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets
Swayze, E. E., Jefferson, E. A., Sannes, K. A., Blyn, L. B., Risen, L. M., Arakawa, S., Osgood, S. A., Hofstadler, S. A., & Griffey, R. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255466 · Cited by 145
Raju, T. N. K. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74775-9 · Cited by 133
Baurin, N., Baker, R., Richardson, C., Chen, I., Foloppe, N., Potter, A., Jordan, A. M., Roughley, S. D., Parratt, M. J., Greaney, P., et al. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034260m · Cited by 123
Comprehensive Survey of Combinatorial Library Synthesis: 2002
Dolle, R. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc0340224 · Cited by 117
Chemical genetics: exploring and controlling cellular processes with chemical probes
Crews, C. M., & Splittgerber, U. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01425-5 · Cited by 116
Molecular properties that influence oral drug-like behavior.
Lajiness, M. S., Vieth, M., & Erickson, J. A. (2004) · PubMed · Cited by 102
Sills, M. A., Weiss, D., Pham, Q., Schweitzer, R. H., Wu, X. Y., & Wu, J. J. (2002) · SLAS DISCOVERY · doi:10.1177/108705710200700304 · Cited by 101
Prediction of Biological Activity for High-Throughput Screening Using Binary Kernel Discrimination
Harper, G., Bradshaw, J., Gittins, J. C., Green, D. V. S., & Leach, A. R. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000397q · Cited by 100
Lesuisse, D., Lange, G., Deprez, P., Bénard, D., Schoot, B. M., Delettre, G., Marquette, J.-P., Broto, P., Jean‐Baptiste, V., Bichet, P., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010927p · Cited by 90
Chemical space navigation in lead discovery
Oprea, T. I. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00329-0 · Cited by 87
Drug prototypes and their exploitation
(1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)90084-7 · Cited by 78
Guiding molecules towards drug-likeness.
Egan, W. J., Walters, W. P., & Murcko, M. A. (2002) · PubMed · Cited by 56
Wang, J., & Ramnarayan, K. (1999) · Journal of Combinatorial Chemistry · doi:10.1021/cc990032m · Cited by 55
Wu, X. Y., Glickman, J. F., Bowen, B. R., & Sills, M. A. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103256466 · Cited by 46
Target Analysis: A Priori Assessment of Druggability
Hopkins, A. L., & Groom, C. R. (2003) · Springer eBooks · doi:10.1007/978-3-662-05314-0_2 · Cited by 45
Self-citationAntibody libraries in drug and target discovery
Rader, C. M. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01595-6 · Cited by 38
Modeling drug action in the mouse with knockouts and RNA interference
Zambrowicz, B., & Sands, A. (2004) · Drug Discovery Today TARGETS · doi:10.1016/s1741-8372(04)02454-5 · Cited by 31
Outlier Mining in High Throughput Screening Experiments
Engels, M. F. M., Wouters, L., Verbeeck, R., & Vanhoof, G. (2002) · Journal of biomolecular screening · doi:10.1089/108705702320351196 · Cited by 26
Thirty‐three years of drug discovery and research with Dr. Paul Janssen
van Gestel, S., & Schuermans, V. (1986) · Drug Development Research · doi:10.1002/ddr.430080103 · Cited by 19
Kolb (2001) · doi:10.1002/1521-3773(20010601)40:11<2004::aid-anie2004>3.0.co;2-5
Cited by
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
SwissParam: A fast force field generation tool for small organic molecules
Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21816 · Cited by 2,370
Catalytic C–H functionalization by metal carbenoid and nitrenoid insertion
Davies, H. M. L., & Manning, J. R. (2008) · Nature · doi:10.1038/nature06485 · Cited by 2,303
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Multicomponent Reaction Design in the Quest for Molecular Complexity and Diversity
Ruijter, E., Scheffelaar, R., & Orru, R. V. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006515 · Cited by 1,329
Metadata
- Authors
- Lipinski, C., & Hopkins, A.
- Venue
- Nature
- Published
- 2004-12
- Volume
- 432
- Issue
- 7019
- Pages
- 855-861
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061843861
- Cited by
- 1,002
- References
- 64
- FWCI
- 43.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.